Rilpivirine hydrochloride | Radio Compass News | PharmaCompass.com

Grow Your Pharma Business Digitally

X

Market Place

Sourcing support

Sourcing Support

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

All News Rilpivirine Hydrochloride

NICE says yes to GSK`s Cabenuva, new option for HIV patients

19 Nov 2021 //

FIERCEPHARMA

ViiV sees first global approval of Cabenuva in Canada

23 Mar 2020 //

PHARMATIMES

FDA Confirms Paragraph IV Patent Challenge of Odefsey 208351 (Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate )Tablets

07 Jan 2020 //

FDA

FDA slams GSK`s monthly HIV injectable with CRL, citing manufacturing issues

24 Dec 2019 //

ENDPTS

J&J-backed AIDS film picked up by Verizon Media

10 May 2019 //

FIERCE PHARMA

Prescription med: new or extended uses, new combinations of registered medicines

09 Jul 2018 //

TGA

Fresh off its Juluca approval, GSK beefs up trials of long-acting HIV duo

28 Nov 2017 //

FIERCE PHARMA

ViiV’s long-acting two-drug HIV regimen hits targets

25 Jul 2017 //

PHARMA TIMES

With two-drug combo data, GSK primes for an HIV market-share steal

15 Feb 2017 //

FIERCE PHARMA

Gilead`s latest HIV cocktail wins FDA approval with a blockbuster pedigree

01 Mar 2016 //

FIERCE BIOTECH

J&J and ViiV line up Phase III trials for a long-acting HIV treatment

25 Feb 2016 //

FIERCE BIOTECH

ViiV to Progress Collaboration with Janssen to Develop First Long-acting

08 Jan 2016 //

PR NEWS WIRE

ViiV Announces Positive Results from a Study for HIV Maintenance Therapy

04 Nov 2015 //

PR NEWS WIRE

Gilead`s low-dose, high-impact HIV drug heads to the FDA

09 Apr 2015 //

SAN FRANSISCO BUSINESS TIMES

Gilead Announces Amended Agreements with Janssen to Develop and Commercialize Tenofovir Alafenamide-Based Single Tablet Regimens for HIV Treatment

29 Dec 2014 //

BIOSPECTRUM ASIA